CSI Market
Sign In | Register

Xenon Pharmaceuticals Inc (XENE) Annual Balance Sheets

Annual · GAAP · USD millions
Access XENE quarterly Balance Sheets →
From Xenon Pharmaceuticals Inc through Dec 31 2021, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent199.16
Marketable Securities, Current SH349.72
Cash & Short-term Investments548.00
Accounts receivable0.00
Other Receivables, Net, Current1.37
Prepaid Expense And Other Assets Current10.39
Total Current Assets560.65
Equipment/Property/Plant Net8.72
Long-term investments37.15
Prepaid Expense, Noncurrent, Total PR7.15
Other Assets, Noncurrent56.64
Operating Lease Right Of Use Asset6.63
Total Assets633.16
Liabilities
Accounts Payable and Accrued Liabilities, Current LI40.26
Other Liabilities, Current1.53
Total Current Liabilities41.79
Total Long-term Debt0.00
Other liabilities, Noncurrent9.61
Operating Lease Liability Current1.53
Operating Lease Liability Noncurrent6.41
Total Liabilities51.40
Stockholders' Equity
Common Stock Value1,598.57
Additional Paid In Capital Common Stock228.23
Retained Earnings / Accumulated Deficit-1,245.38
Other Equity0.34
Common Stockholder's Equity581.76
Preferred Stockholder's Equity0.00
Total Stockholder's Equity581.76
Liabilities & Stockholder's Equity633.16
4 historic quarters locked

Sign in to unlock the full Xenon Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Xenon Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: xene-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-076650

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License